| Integrative analysis of 111 reference human epigenomes A Kundaje, W Meuleman, J Ernst, M Bilenky, A Yen, A Heravi-Moussavi, ... Nature 518 (7539), 317-330, 2015 | 6179 | 2015 |
| Mutational landscape and significance across 12 major cancer types C Kandoth, MD McLellan, F Vandin, K Ye, B Niu, C Lu, M Xie, Q Zhang, ... Nature 502 (7471), 333-339, 2013 | 4797 | 2013 |
| Age-related mutations associated with clonal hematopoietic expansion and malignancies M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ... Nature medicine 20 (12), 1472-1478, 2014 | 1967 | 2014 |
| MSIsensor: microsatellite instability detection using paired tumor-normal sequence data B Niu, K Ye, Q Zhang, C Lu, M Xie, MD McLellan, MC Wendl, L Ding Bioinformatics 30 (7), 1015-1016, 2013 | 694 | 2013 |
| Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends … DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ... Journal for immunotherapy of cancer 8 (1), 2020 | 403 | 2020 |
| The human epigenome browser at Washington University X Zhou, B Maricque, M Xie, D Li, V Sundaram, EA Martin, BC Koebbe, ... Nature methods 8 (12), 989-990, 2011 | 345 | 2011 |
| Integrated analysis of germline and somatic variants in ovarian cancer KL Kanchi, KJ Johnson, C Lu, MD McLellan, MDM Leiserson, MC Wendl, ... Nature communications 5 (1), 3156, 2014 | 320 | 2014 |
| Patterns and functional implications of rare germline variants across 12 cancer types C Lu, M Xie, MC Wendl, J Wang, MD McLellan, MDM Leiserson, K Huang, ... Nature communications 6 (1), 10086, 2015 | 310 | 2015 |
| DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape M Xie, C Hong, B Zhang, RF Lowdon, X Xing, D Li, X Zhou, HJ Lee, ... Nature genetics 45 (7), 836–841, 2013 | 247 | 2013 |
| Comparative epigenomic annotation of regulatory DNA S Xiao, D Xie, X Cao, P Yu, X Xing, CC Chen, M Musselman, M Xie, ... Cell 149 (6), 1381-1392, 2012 | 218 | 2012 |
| Estimating absolute methylation levels at single-CpG resolution from methylation enrichment and restriction enzyme sequencing methods M Stevens, JB Cheng, D Li, M Xie, C Hong, CL Maire, KL Ligon, M Hirst, ... Genome research 23 (9), 1541-1553, 2013 | 180 | 2013 |
| Systematic discovery of complex insertions and deletions in human cancers K Ye, J Wang, R Jayasinghe, EW Lameijer, JF McMichael, J Ning, ... Nature medicine 22 (1), 97-104, 2016 | 122 | 2016 |
| Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project DM Vega, LM Yee, LM McShane, PM Williams, L Chen, T Vilimas, ... Annals of Oncology 32 (12), 1626-1636, 2021 | 105 | 2021 |
| Divergent viral presentation among human tumors and adjacent normal tissues S Cao, MC Wendl, MA Wyczalkowski, K Wylie, K Ye, R Jayasinghe, M Xie, ... Scientific reports 6 (1), 28294, 2016 | 73 | 2016 |
| The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis KB Jones, JJ Barrott, M Xie, M Haldar, H Jin, JF Zhu, MJ Monument, ... Oncogene 35 (38), 5021-5032, 2016 | 49 | 2016 |
| STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1 TA Proia, M Singh, R Woessner, L Carnevalli, G Bommakanti, L Magiera, ... Clinical Cancer Research 26 (23), 6335-6349, 2020 | 42 | 2020 |
| Multifactorial deep learning reveals pan-cancer genomic tumor clusters with distinct immunogenomic landscape and response to immunotherapy F Xie, J Zhang, J Wang, A Reuben, W Xu, X Yi, FS Varn, Y Ye, J Cheng, ... Clinical Cancer Research 26 (12), 2908-2920, 2020 | 40 | 2020 |
| High Frequency Strand Slippage Mutations in CTCF in MSI‐Positive Endometrial Cancers I Zighelboim, DG Mutch, A Knapp, L Ding, M Xie, DE Cohn, PJ Goodfellow Human mutation 35 (1), 63-65, 2013 | 36 | 2013 |
| The clear cell sarcoma functional genomic landscape E Panza, BB Ozenberger, KM Straessler, JJ Barrott, L Li, Y Wang, M Xie, ... The Journal of Clinical Investigation 131 (15), 2021 | 26 | 2021 |
| LBA86 Durvalumab (D)±tremelimumab (T)+ platinum-etoposide (EP) in 1L ES-SCLC: Characterization of long-term clinical benefit and tumour mutational burden (TMB) in CASPIAN JW Goldman, MC Garassino, Y Chen, N Reinmuth, K Hotta, A Poltoratskiy, ... Annals of Oncology 31, S1212-S1213, 2020 | 24 | 2020 |
Michael WendlAssociate Professor, Washington University在 wustl.edu 的电子邮件经过验证
